A novel point mutation within the juxtamembrane domain of the flt3 gene in acute myeloid leukemia

被引：0

作者：

Valentina Gianfelici

Daniela Diverio

Massimo Breccia

Sonia Buffolino

Valentina Derme

Attilio Di Lascio

Marilisa Marinelli

Simona Santangelo

Giovanna Meloni

Robin Foà

机构：

[1] “Sapienza” University of Rome,Division of Hematology, Department of Cellular Biotechnologies and Hematology

来源：

Annals of Hematology | 2011年 / 90卷

关键词：

Acute Myeloid Leukemia; Acute Myeloid Leukemia Patient; Internal Tandem Duplication; Denature High Performance Liquid Chromatography; FLT3 Inhibitor;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：845 / 846

页数：1

共 50 条

[31] FLT3 Gene Mutations in Acute Myeloid Leukemia Patients in Northeast Thailand [J].

Aung, Nang Ei Ei ;

Yamsri, Supawadee ;

Teawtrakul, Nattiya ;

Kamsaen, Piyawan ;

Fucharoen, Supan .

MEDICAL SCIENCE MONITOR BASIC RESEARCH, 2022, 28 :e937446

[32] Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation [J].

Ballesta-Lopez, Octavio ;

Solana-Altabella, Antonio ;

Megias-Vericat, Juan Eduardo ;

Martinez-Cuadron, David ;

Montesinos, Pau .

FUTURE ONCOLOGY, 2020, 17 (02) :215-228

[33] The role of FLT3 inhibitors in the treatment of FLT3-mutated acute myeloid leukemia [J].

Fathi, Amir T. ;

Chen, Yi-Bin .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (04) :330-336

[34] Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features [J].

Pradeep S. Chauhan ;

Bharat Bhushan ;

Ashwani K. Mishra ;

Laishram C. Singh ;

Sumita Saluja ;

Saurabh Verma ;

Dipendra K. Gupta ;

Vishakha Mittal ;

Sumita Chaudhry ;

Sujala Kapur .

Medical Oncology, 2011, 28 :544-551

[35] Novel treatments for relapsed/refractory acute myeloid leukemia with FLT3 mutations [J].

Tallis, Eran ;

Borthakur, Gautam .

EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (08) :621-640

[36] Acute Myeloid Leukemia Associated With Near-Tetraploid Karyotype and Mutations in the FLT3 Gene [J].

Jurisic, Vladimir ;

Pavlovic, Sonja ;

Colovic, Natasa ;

Djordjevic, Vesna ;

Jankovic, Gradimir ;

Colovic, Milica .

LABMEDICINE, 2011, 42 (09) :540-543

[37] Prevalence and Clinical Significance of FLT3 Mutation Status in Acute Myeloid Leukemia Patients: A Multicenter Study [J].

Cuervo-Sierra, Jorge ;

Carlos Jaime-Perez, Jose ;

Martinez-Hernandez, Ramon A. ;

Garcia-Sepulveda, Ricardo D. ;

Sanchez-Cardenas, Monica ;

Gomez-Almaguer, David ;

Ortiz-Lopez, Rocio ;

Villarreal-Villarreal, Cesar D. ;

Ruiz-Arguelles, Guillermo J. ;

Ruiz-Delgado, Guillermo ;

Lutz-Presno, Julia ;

Garces-Eisele, Javier ;

Ignacio-Ibarra, Gregorio ;

Mucino-Hernandez, Gabriel ;

Arana-Trejo, Rosa M. ;

Jimenez-Mejia, Angelica M. ;

Vasquez-Palacio, Gonzalo .

ARCHIVES OF MEDICAL RESEARCH, 2016, 47 (03) :172-179

[38] Results of FLT3 mutation screening and correlations with immunophenotyping in 169 Brazilian patients with acute myeloid leukemia [J].

Antonio R. Lucena-Araujo ;

Danielle L. Souza ;

Fabio Morato de Oliveira ;

Mariana Tereza Lira Benicio ;

Lorena L. Figueiredo-Pontes ;

Barbara A. Santana-Lemos ;

Guilherme A. dos Santos ;

Rafael H. Jacomo ;

Anemari R. Dinarte-Santos ;

Mihoko Yamamoto ;

Wilson A. Silva-Jr ;

Maria de Lourdes Chauffaille ;

Eduardo M. Rego .

Annals of Hematology, 2010, 89 :225-228

[39] Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia [J].

Wang, Eunice S. .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (02) :154-162

[40] Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia [J].

Short, Nicholas J. ;

Kantarjian, Hagop ;

Ravandi, Farhad ;

Daver, Naval .

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10

← 1 2 3 4 5 →